ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 0222

Primary Care Provider Utilization of Musculoskeletal Ultrasound for the Diagnosis of Acute Gout Flares: A Novel Opportunity for Rheumatology-Focused Educational Curricula

Wes Cubberley1, Taylor Nelson1, Michael Battistone2, Andrea Barker2, Jeremy Timm3, Anthony Minjarez2 and Gary Kunkel1, 1University of Utah, Salt Lake City, UT, 2Salt Lake City VA, Salt Lake City, UT, 3Salt Lake City VA, Salt Lake City

Meeting: ACR Convergence 2022

Keywords: education, medical, gout, primary care, Surveys, Ultrasound

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Saturday, November 12, 2022

Title: Professional Education Poster

Session Type: Poster Session A

Session Time: 1:00PM-3:00PM

Background/Purpose: Gout, the most common inflammatory arthritis, can be challenging to identify, especially when clinical criteria are insufficient to support a diagnosis. Musculoskeletal ultrasound (MSK US) can aid in this, particularly during acute flares. However, MSK US is not often used in primary care settings when patients present with inflammatory arthritis suggestive of acute gout. Given its recent emergence in medical education, most practicing primary care providers (PCPs) are unlikely to have had training in MSK US, and thus a gap in knowledge and technical skill exists. The aim of our study was to assess PCPs’ experiences, interest, and perceived barriers to using MSK US in diagnosis of gout flares. This project is part of a broader needs assessment to inform a continuing professional development (CPD) program for PCPs.

Methods: A pilot survey was developed and Messick’s framework was used to evaluate validity evidence from content and response process. 3 rheumatology faculty and 2 PCPs defined 2 constructs of interest through literature review and reflective critique. These were: 1) PCPs’ current practices using MSK US when considering gout and 2) envisioned barriers to using MSK US in PCP clinics. The survey was systematically reviewed for relevance to the constructs and clarity of each item. Content validity index (CVI) was calculated for each item and items with a CVI < 0.8 were eliminated. Cognitive interviewing then clarified the mental model emerging through survey use. The final survey was distributed for pilot testing on REDCap® software to 67 PCPs at several Veterans Affairs primary care clinics from 5/10/2021 to 10/19/2021.

Results: The final survey contained 17 items. 24 participants (response rate = 36%) completed the survey (Table 1). Reported practice patterns for PCPs are represented in Figure 1. Respondents’ diagnostic approach included lab testing and x-rays, and over half treated presumed gout flares empirically at least “sometimes”. Regardless of professional credential or experience, respondents did not report confidence in their ability to use MSK US; most reported strong interest in developing this skill (Figure 2). PCPs signaled that given minimal disruption to clinical workflow and US machine availability, they envisioned incorporating MSK US in their workplace.

Conclusion: Despite the currently limited utilization of MSK US for the diagnosis of gout in primary care settings, PCPs have strong interest in learning to use MSK US to evaluate patients presenting with possible gout, indicating they would use MSK US if a machine were available and they had the knowledge to operate and interpret the findings of their examinations. These findings support development of curricula targeted to practicing PCPs interested in learning MSK US for the diagnosis of gout flares. Because content expertise rests with rheumatologists, this represents an opportunity for clinician-scholar-educators to collaborate with PCP leaders with context expertise in developing a new rheumatology-related curricula for CPD.

Supporting image 1

Supporting image 2

Supporting image 3


Disclosures: W. Cubberley, None; T. Nelson, None; M. Battistone, None; A. Barker, None; J. Timm, None; A. Minjarez, None; G. Kunkel, None.

To cite this abstract in AMA style:

Cubberley W, Nelson T, Battistone M, Barker A, Timm J, Minjarez A, Kunkel G. Primary Care Provider Utilization of Musculoskeletal Ultrasound for the Diagnosis of Acute Gout Flares: A Novel Opportunity for Rheumatology-Focused Educational Curricula [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/primary-care-provider-utilization-of-musculoskeletal-ultrasound-for-the-diagnosis-of-acute-gout-flares-a-novel-opportunity-for-rheumatology-focused-educational-curricula/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/primary-care-provider-utilization-of-musculoskeletal-ultrasound-for-the-diagnosis-of-acute-gout-flares-a-novel-opportunity-for-rheumatology-focused-educational-curricula/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology